UniProt ID | PTPRF_HUMAN | |
---|---|---|
UniProt AC | P10586 | |
Protein Name | Receptor-type tyrosine-protein phosphatase F | |
Gene Name | PTPRF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1907 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | Possible cell adhesion receptor. It possesses an intrinsic protein tyrosine phosphatase activity (PTPase) and dephosphorylates EPHA2 regulating its activity.; The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one.. | |
Protein Sequence | MAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEVIEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFKDFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPMPYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKALPKPPIDLVVTETTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQAPSSPPRRVQARMLSASTMLVQWEPPEEPNGLVRGYRVYYTPDSRRPPNAWHKHNTDAGLLTTVGSLLPGITYSLRVLAFTAVGDGPPSPTIQVKTQQGVPAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDEDVPSGPPRKVEVEPLNSTAVHVYWKLPVPSKQHGQIRGYQVTYVRLENGEPRGLPIIQDVMLAEAQWRPEESEDYETTISGLTPETTYSVTVAAYTTKGDGARSKPKIVTTTGAVPGRPTMMISTTAMNTALLQWHPPKELPGELLGYRLQYCRADEARPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFEKEIRTPEDLPSGFPQNLHVTGLTTSTTELAWDPPVLAERNGRIISYTVVFRDINSQQELQNITTDTRFTLTGLKPDTTYDIKVRAWTSKGSGPLSPSIQSRTMPVEQVFAKNFRVAAAMKTSVLLSWEVPDSYKSAVPFKILYNGQSVEVDGHSMRKLIADLQPNTEYSFVLMNRGSSAGGLQHLVSIRTAPDLLPHKPLPASAYIEDGRFDLSMPHVQDPSLVRWFYIVVVPIDRVGGSMLTPRWSTPEELELDELLEAIEQGGEEQRRRRRQAERLKPYVAAQLDVLPETFTLGDKKNYRGFYNRPLSPDLSYQCFVLASLKEPMDQKRYASSPYSDEIVVQVTPAQQQEEPEMLWVTGPVLAVILIILIVIAILLFKRKRTHSPSSKDEQSIGLKDSLLAHSSDPVEMRRLNYQTPGMRDHPPIPITDLADNIERLKANDGLKFSQEYESIDPGQQFTWENSNLEVNKPKNRYANVIAYDHSRVILTSIDGVPGSDYINANYIDGYRKQNAYIATQGPLPETMGDFWRMVWEQRTATVVMMTRLEEKSRVKCDQYWPARGTETCGLIQVTLLDTVELATYTVRTFALHKSGSSEKRELRQFQFMAWPDHGVPEYPTPILAFLRRVKACNPLDAGPMVVHCSAGVGRTGCFIVIDAMLERMKHEKTVDIYGHVTCMRSQRNYMVQTEDQYVFIHEALLEAATCGHTEVPARNLYAHIQKLGQVPPGESVTAMELEFKLLASSKAHTSRFISANLPCNKFKNRLVNIMPYELTRVCLQPIRGVEGSDYINASFLDGYRQQKAYIATQGPLAESTEDFWRMLWEHNSTIIVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTIRQFQFTDWPEQGVPKTGEGFIDFIGQVHKTKEQFGQDGPITVHCSAGVGRTGVFITLSIVLERMRYEGVVDMFQTVKTLRTQRPAMVQTEDQYQLCYRAALEYLGSFDHYAT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
117 | N-linked_Glycosylation | TNSLGEINTSAKLSV CCCCCCCCCCCCEEE | 24.55 | UniProtKB CARBOHYD | |
144 | Ubiquitination | IDMGPQLKVVEKART CCCCCCEEHHHHHHH | 38.70 | 21906983 | |
144 (in isoform 1) | Ubiquitination | - | 38.70 | 21890473 | |
144 (in isoform 2) | Ubiquitination | - | 38.70 | 21890473 | |
200 | O-linked_Glycosylation | QIESSEESDQGKYEC EEECCCCHHCCEEEE | 31.05 | - | |
200 | O-linked_Glycosylation | QIESSEESDQGKYEC EEECCCCHHCCEEEE | 31.05 | 9295285 | |
205 | Phosphorylation | EESDQGKYECVATNS CCHHCCEEEEEEECC | 22.76 | 20068231 | |
210 | Phosphorylation | GKYECVATNSAGTRY CEEEEEEECCCCCCE | 14.87 | 20068231 | |
212 | Phosphorylation | YECVATNSAGTRYSA EEEEEECCCCCCEEC | 24.58 | 20068231 | |
215 | Phosphorylation | VATNSAGTRYSAPAN EEECCCCCCEECCCE | 26.59 | 20068231 | |
217 | Phosphorylation | TNSAGTRYSAPANLY ECCCCCCEECCCEEE | 14.71 | 30576142 | |
218 | O-linked_Glycosylation | NSAGTRYSAPANLYV CCCCCCEECCCEEEE | 25.20 | OGP | |
218 | Phosphorylation | NSAGTRYSAPANLYV CCCCCCEECCCEEEE | 25.20 | 30576142 | |
224 | Phosphorylation | YSAPANLYVRVRRVA EECCCEEEEEEEEEC | 5.99 | 30576142 | |
248 | Phosphorylation | QEVMPGGSVNLTCVA CCCCCCCCEEEEEEE | 17.47 | 23879269 | |
250 | N-linked_Glycosylation | VMPGGSVNLTCVAVG CCCCCCEEEEEEEEC | 31.18 | UniProtKB CARBOHYD | |
262 | Phosphorylation | AVGAPMPYVKWMMGA EECCCCCHHHHHHCC | 14.38 | 23879269 | |
274 | Ubiquitination | MGAEELTKEDEMPVG HCCHHCCCCCCCCCC | 75.65 | 21906983 | |
274 (in isoform 1) | Ubiquitination | - | 75.65 | 21890473 | |
274 (in isoform 2) | Ubiquitination | - | 75.65 | 21890473 | |
295 | N-linked_Glycosylation | SNVVRSANYTCVAIS HHHHHHCCCEEEEEE | 33.61 | UniProtKB CARBOHYD | |
296 | Phosphorylation | NVVRSANYTCVAISS HHHHHCCCEEEEEEC | 10.96 | - | |
348 | O-linked_Glycosylation | SGNSEPVTYYGIQYR CCCCCCEEEEEEEEE | 23.03 | OGP | |
359 | O-linked_Glycosylation | IQYRAAGTEGPFQEV EEEEECCCCCCCCEE | 32.80 | OGP | |
359 | Phosphorylation | IQYRAAGTEGPFQEV EEEEECCCCCCCCEE | 32.80 | 21406692 | |
371 | Phosphorylation | QEVDGVATTRYSIGG CEECCEEEEEEECCC | 14.92 | 21406692 | |
372 | Phosphorylation | EVDGVATTRYSIGGL EECCEEEEEEECCCC | 20.19 | 21406692 | |
380 | Phosphorylation | RYSIGGLSPFSEYAF EEECCCCCCHHHHHH | 27.46 | - | |
394 | Phosphorylation | FRVLAVNSIGRGPPS HHHHHHHCCCCCCCH | 21.59 | 21406692 | |
447 | Phosphorylation | PNGLVRGYRVYYTPD CCCEECEEEEEECCC | 6.07 | 24043423 | |
450 | Phosphorylation | LVRGYRVYYTPDSRR EECEEEEEECCCCCC | 7.82 | 24043423 | |
451 | Phosphorylation | VRGYRVYYTPDSRRP ECEEEEEECCCCCCC | 14.67 | 24043423 | |
452 | Phosphorylation | RGYRVYYTPDSRRPP CEEEEEECCCCCCCC | 11.70 | 24043423 | |
455 | Phosphorylation | RVYYTPDSRRPPNAW EEEECCCCCCCCCCC | 31.24 | 24043423 | |
485 | Phosphorylation | LLPGITYSLRVLAFT HCCCCCEEEEEEEEE | 10.89 | 24719451 | |
507 | O-linked_Glycosylation | SPTIQVKTQQGVPAQ CCEEEEEECCCCCCC | 27.54 | OGP | |
568 | O-linked_Glycosylation | FDPTSSYTLEDLKPD ECCCCCCCHHHCCCC | 26.14 | OGP | |
594 | Phosphorylation | DMGVGVFTPTIEART CCCCCEECCCEEEEC | 19.67 | - | |
596 | Phosphorylation | GVGVFTPTIEARTAQ CCCEECCCEEEECCC | 28.52 | - | |
601 | Phosphorylation | TPTIEARTAQSTPSA CCCEEEECCCCCCCC | 35.78 | 23090842 | |
604 | Phosphorylation | IEARTAQSTPSAPPQ EEEECCCCCCCCCCC | 39.56 | 23090842 | |
605 | Phosphorylation | EARTAQSTPSAPPQK EEECCCCCCCCCCCE | 14.80 | 23090842 | |
607 | Phosphorylation | RTAQSTPSAPPQKVM ECCCCCCCCCCCEEE | 54.20 | 23090842 | |
617 | Phosphorylation | PQKVMCVSMGSTTVR CCEEEEEECCCCEEE | 16.70 | 23090842 | |
620 | Phosphorylation | VMCVSMGSTTVRVSW EEEEECCCCEEEEEE | 16.56 | 23090842 | |
621 | Phosphorylation | MCVSMGSTTVRVSWV EEEECCCCEEEEEEC | 24.47 | 23090842 | |
622 | Phosphorylation | CVSMGSTTVRVSWVP EEECCCCEEEEEECC | 14.17 | 23090842 | |
688 | Phosphorylation | RVWVRAHTDVGPGPE EEEEEECCCCCCCCC | 31.25 | 22210691 | |
697 | Phosphorylation | VGPGPESSPVLVRTD CCCCCCCCCEEEECC | 19.84 | 22210691 | |
703 | Phosphorylation | SSPVLVRTDEDVPSG CCCEEEECCCCCCCC | 35.94 | - | |
709 | Phosphorylation | RTDEDVPSGPPRKVE ECCCCCCCCCCCEEE | 64.87 | - | |
721 | N-linked_Glycosylation | KVEVEPLNSTAVHVY EEEEEECCCCEEEEE | 48.29 | UniProtKB CARBOHYD | |
777 | Phosphorylation | AQWRPEESEDYETTI CCCCCCCCCCCEEEC | 33.82 | 30576142 | |
788 | Phosphorylation | ETTISGLTPETTYSV EEECCCCCCCCEEEE | 23.70 | 30576142 | |
794 | Phosphorylation | LTPETTYSVTVAAYT CCCCCEEEEEEEEEE | 14.82 | 30576142 | |
816 | Phosphorylation | SKPKIVTTTGAVPGR CCCEEEEECCCCCCC | 16.61 | - | |
817 | Phosphorylation | KPKIVTTTGAVPGRP CCEEEEECCCCCCCC | 17.49 | - | |
825 | Phosphorylation | GAVPGRPTMMISTTA CCCCCCCEEEEEECC | 20.29 | - | |
830 | O-linked_Glycosylation | RPTMMISTTAMNTAL CCEEEEEECCHHHHH | 13.98 | OGP | |
959 | N-linked_Glycosylation | TVVFRDINSQQELQN EEEEECCCCHHHHCC | 37.75 | 19349973 | |
959 | N-linked_Glycosylation | TVVFRDINSQQELQN EEEEECCCCHHHHCC | 37.75 | 19349973 | |
966 | N-linked_Glycosylation | NSQQELQNITTDTRF CCHHHHCCCCCCCCE | 46.31 | UniProtKB CARBOHYD | |
966 | N-linked_Glycosylation | NSQQELQNITTDTRF CCHHHHCCCCCCCCE | 46.31 | 16335952 | |
968 | Phosphorylation | QQELQNITTDTRFTL HHHHCCCCCCCCEEE | 26.60 | 26074081 | |
969 | Phosphorylation | QELQNITTDTRFTLT HHHCCCCCCCCEEEC | 31.41 | 26074081 | |
971 | Phosphorylation | LQNITTDTRFTLTGL HCCCCCCCCEEECCC | 26.12 | 26074081 | |
974 | Phosphorylation | ITTDTRFTLTGLKPD CCCCCCEEECCCCCC | 21.81 | 26074081 | |
976 | Phosphorylation | TDTRFTLTGLKPDTT CCCCEEECCCCCCCE | 37.09 | 26074081 | |
996 | Phosphorylation | RAWTSKGSGPLSPSI EEEECCCCCCCCCCH | 40.76 | 24719451 | |
1000 | Phosphorylation | SKGSGPLSPSIQSRT CCCCCCCCCCHHCCC | 21.53 | - | |
1007 | O-linked_Glycosylation | SPSIQSRTMPVEQVF CCCHHCCCCCHHHHH | 30.95 | OGP | |
1025 | Acetylation | FRVAAAMKTSVLLSW HHHHHHHCEEEEEEE | 32.68 | 19820855 | |
1026 | Phosphorylation | RVAAAMKTSVLLSWE HHHHHHCEEEEEEEE | 15.81 | - | |
1027 | Phosphorylation | VAAAMKTSVLLSWEV HHHHHCEEEEEEEEC | 12.78 | - | |
1031 | Phosphorylation | MKTSVLLSWEVPDSY HCEEEEEEEECCCCC | 19.61 | - | |
1045 | Acetylation | YKSAVPFKILYNGQS CCCCCCEEEEECCEE | 26.23 | 19820861 | |
1092 | Phosphorylation | GGLQHLVSIRTAPDL CCHHHHEEEEECCCC | 16.83 | 24719451 | |
1108 | Phosphorylation | PHKPLPASAYIEDGR CCCCCCCCEEEECCC | 21.47 | 30257219 | |
1110 | Phosphorylation | KPLPASAYIEDGRFD CCCCCCEEEECCCEE | 11.44 | 30257219 | |
1286 (in isoform 2) | Ubiquitination | - | 26.76 | 21890473 | |
1289 | Phosphorylation | LLFKRKRTHSPSSKD HHHHHCCCCCCCCCC | 29.73 | 20873877 | |
1291 | Phosphorylation | FKRKRTHSPSSKDEQ HHHCCCCCCCCCCHH | 26.34 | 20873877 | |
1293 | Phosphorylation | RKRTHSPSSKDEQSI HCCCCCCCCCCHHCC | 53.70 | 20873877 | |
1294 | Phosphorylation | KRTHSPSSKDEQSIG CCCCCCCCCCHHCCC | 47.73 | 25849741 | |
1294 (in isoform 2) | Ubiquitination | - | 47.73 | 21890473 | |
1295 | Ubiquitination | RTHSPSSKDEQSIGL CCCCCCCCCHHCCCC | 70.40 | 21906983 | |
1295 (in isoform 1) | Ubiquitination | - | 70.40 | 21890473 | |
1299 | Phosphorylation | PSSKDEQSIGLKDSL CCCCCHHCCCCCHHH | 19.31 | 30266825 | |
1303 | Ubiquitination | DEQSIGLKDSLLAHS CHHCCCCCHHHHHCC | 39.81 | 21906983 | |
1303 (in isoform 1) | Ubiquitination | - | 39.81 | 21890473 | |
1305 | Phosphorylation | QSIGLKDSLLAHSSD HCCCCCHHHHHCCCC | 24.56 | 30266825 | |
1310 | Phosphorylation | KDSLLAHSSDPVEMR CHHHHHCCCCHHHHH | 30.72 | 25849741 | |
1311 | Phosphorylation | DSLLAHSSDPVEMRR HHHHHCCCCHHHHHH | 35.75 | 25849741 | |
1321 | Phosphorylation | VEMRRLNYQTPGMRD HHHHHCCCCCCCCCC | 20.53 | 21945579 | |
1323 | Phosphorylation | MRRLNYQTPGMRDHP HHHCCCCCCCCCCCC | 16.08 | 21945579 | |
1335 | Phosphorylation | DHPPIPITDLADNIE CCCCCCHHHHHHHHH | 21.43 | 24719451 | |
1345 | 2-Hydroxyisobutyrylation | ADNIERLKANDGLKF HHHHHHHHHCCCCCC | 51.90 | - | |
1345 | Ubiquitination | ADNIERLKANDGLKF HHHHHHHHHCCCCCC | 51.90 | - | |
1351 | Ubiquitination | LKANDGLKFSQEYES HHHCCCCCCCCCCCC | 48.80 | - | |
1356 | Phosphorylation | GLKFSQEYESIDPGQ CCCCCCCCCCCCCCC | 13.82 | - | |
1367 (in isoform 2) | Ubiquitination | - | 12.22 | 21890473 | |
1376 | Ubiquitination | NSNLEVNKPKNRYAN CCCCEECCCCCCEEE | 63.65 | 21906983 | |
1376 (in isoform 1) | Ubiquitination | - | 63.65 | 21890473 | |
1381 | Phosphorylation | VNKPKNRYANVIAYD ECCCCCCEEEEEEEC | 16.36 | 21945579 | |
1387 | Phosphorylation | RYANVIAYDHSRVIL CEEEEEEECCCEEEE | 11.76 | 28796482 | |
1390 | Phosphorylation | NVIAYDHSRVILTSI EEEEECCCEEEEEEC | 25.91 | 28796482 | |
1403 | Phosphorylation | SIDGVPGSDYINANY ECCCCCCCCCCCCEE | 22.59 | 27642862 | |
1405 | Phosphorylation | DGVPGSDYINANYID CCCCCCCCCCCEECC | 9.58 | 27642862 | |
1410 | Phosphorylation | SDYINANYIDGYRKQ CCCCCCEECCCCCCC | 9.66 | - | |
1459 | Malonylation | LEEKSRVKCDQYWPA CHHHHCCCCCCCCCC | 30.86 | 26320211 | |
1572 | Ubiquitination | LERMKHEKTVDIYGH HHHHCCCCCEEEEEE | 54.27 | - | |
1573 | Phosphorylation | ERMKHEKTVDIYGHV HHHCCCCCEEEEEEE | 22.04 | - | |
1577 | Phosphorylation | HEKTVDIYGHVTCMR CCCCEEEEEEEEECC | 9.19 | 27642862 | |
1621 | Phosphorylation | EVPARNLYAHIQKLG CCCHHHHHHHHHHHC | 10.32 | 21945579 | |
1650 | 2-Hydroxyisobutyrylation | FKLLASSKAHTSRFI EHHHHCCCCCHHHHH | 41.51 | - | |
1650 | Ubiquitination | FKLLASSKAHTSRFI EHHHHCCCCCHHHHH | 41.51 | - | |
1665 | Ubiquitination | SANLPCNKFKNRLVN HCCCCHHHHCCCCHH | 65.51 | - | |
1676 | Phosphorylation | RLVNIMPYELTRVCL CCHHCCCHHHHHHHC | 13.24 | 21945579 | |
1679 | Phosphorylation | NIMPYELTRVCLQPI HCCCHHHHHHHCCCC | 14.76 | 21945579 | |
1692 | Phosphorylation | PIRGVEGSDYINASF CCCCCCCCCCCCHHH | 17.46 | 21945579 | |
1694 | Phosphorylation | RGVEGSDYINASFLD CCCCCCCCCCHHHCC | 9.58 | 21945579 | |
1698 | Phosphorylation | GSDYINASFLDGYRQ CCCCCCHHHCCCHHH | 23.12 | 27642862 | |
1703 | Phosphorylation | NASFLDGYRQQKAYI CHHHCCCHHHCCEEE | 12.62 | 27642862 | |
1707 | Ubiquitination | LDGYRQQKAYIATQG CCCHHHCCEEEEECC | 34.51 | - | |
1709 | Phosphorylation | GYRQQKAYIATQGPL CHHHCCEEEEECCCC | 9.72 | 27642862 | |
1748 | Malonylation | LREMGREKCHQYWPA HHHHCHHHHHHHCCC | 35.34 | 26320211 | |
1752 | Phosphorylation | GREKCHQYWPAERSA CHHHHHHHCCCCHHC | 6.95 | - | |
1777 | Phosphorylation | AEYNMPQYILREFKV HHCCCCHHHHHEEEE | 8.96 | - | |
1783 | Ubiquitination | QYILREFKVTDARDG HHHHHEEEEECCCCC | 39.20 | - | |
1785 | Phosphorylation | ILREFKVTDARDGQS HHHEEEEECCCCCCC | 25.24 | - | |
1792 | Phosphorylation | TDARDGQSRTIRQFQ ECCCCCCCEEEEEEE | 36.60 | - | |
1801 (in isoform 2) | Ubiquitination | - | 26.77 | 21890473 | |
1810 | Ubiquitination | WPEQGVPKTGEGFID CCCCCCCCCCCCHHH | 67.75 | 2190698 | |
1810 (in isoform 1) | Ubiquitination | - | 67.75 | 21890473 | |
1824 | Ubiquitination | DFIGQVHKTKEQFGQ HHHHCEEECHHHHCC | 63.54 | - | |
1861 | Phosphorylation | IVLERMRYEGVVDMF HHHHHHCCCCHHHHH | 14.00 | 12496362 | |
1870 | Phosphorylation | GVVDMFQTVKTLRTQ CHHHHHHHHHHHHCC | 16.83 | 28509920 | |
1888 | Phosphorylation | MVQTEDQYQLCYRAA CCCCHHHHHHHHHHH | 18.77 | 21945579 | |
1892 | Phosphorylation | EDQYQLCYRAALEYL HHHHHHHHHHHHHHH | 16.33 | 21945579 | |
1898 | Phosphorylation | CYRAALEYLGSFDHY HHHHHHHHHCCCCCC | 19.74 | - | |
1901 | Phosphorylation | AALEYLGSFDHYAT- HHHHHHCCCCCCCC- | 25.55 | 28176443 | |
1905 | Phosphorylation | YLGSFDHYAT----- HHCCCCCCCC----- | 17.49 | 28796482 | |
1907 | Phosphorylation | GSFDHYAT------- CCCCCCCC------- | 31.79 | 28796482 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTPRF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTPRF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CTNB1_HUMAN | CTNNB1 | physical | 11245482 | |
LIPA1_HUMAN | PPFIA1 | physical | 8524829 | |
LIPA1_HUMAN | PPFIA1 | physical | 7796809 | |
RET_HUMAN | RET | physical | 11121408 | |
TRIO_HUMAN | TRIO | physical | 8643598 | |
CAV1_HUMAN | CAV1 | physical | 12176037 | |
CTNB1_HUMAN | CTNNB1 | physical | 9245795 | |
PLAK_HUMAN | JUP | physical | 9245795 | |
LIPA1_HUMAN | PPFIA1 | physical | 9624153 | |
LIPA3_HUMAN | PPFIA3 | physical | 9624153 | |
LIPA2_HUMAN | PPFIA2 | physical | 9624153 | |
ARBK1_HUMAN | ADRBK1 | physical | 26344197 | |
DAAF5_HUMAN | DNAAF5 | physical | 26344197 | |
NAA50_HUMAN | NAA50 | physical | 26344197 | |
NPL4_HUMAN | NPLOC4 | physical | 26344197 | |
PFKAM_HUMAN | PFKM | physical | 26344197 | |
PICAL_HUMAN | PICALM | physical | 26344197 | |
PPWD1_HUMAN | PPWD1 | physical | 26344197 | |
SPS1_HUMAN | SEPHS1 | physical | 26344197 | |
FCL_HUMAN | TSTA3 | physical | 26344197 | |
UFD1_HUMAN | UFD1L | physical | 26344197 | |
NUDC3_HUMAN | NUDCD3 | physical | 27880917 | |
NAA50_HUMAN | NAA50 | physical | 27880917 | |
TTI1_HUMAN | TTI1 | physical | 27880917 | |
F1712_HUMAN | FAM171A2 | physical | 27880917 | |
TRIO_HUMAN | TRIO | physical | 27880917 | |
SGT1_HUMAN | SUGT1 | physical | 27880917 | |
LIPA1_HUMAN | PPFIA1 | physical | 27880917 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
616001 | Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-959 AND ASN-966, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-966, AND MASSSPECTROMETRY. |